MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Milestone Pharmaceuticals Inc (MIST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.05M | $-21.05M | $-51.15M | $-50.73M | $-33.22M | $-52.47M | $-46.42M | $-28.85M | $-49.04M |
| Capital expenditures | $36000.00 | $5000.00 | $413000.00 | $97000.00 | $0.00 | $272000.00 | $112000.00 | $33000.00 | $302000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $190000.00 | $633000.00 | $1.19M | $4.95M | $7.28M | $9.05M | $9.53M | $5.78M | $7.46M |
| Free cash flow | $-8.09M | $-21.05M | $-51.56M | $-50.83M | $-33.22M | $-52.74M | $-46.54M | $-28.88M | $-49.34M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-47.51M | $41.83M | — | — | — | — |